Pharmacotherapy in congestive heart failure: aldosterone receptor antagonism: interface with hyperkalemia in heart failure.

Congestive heart failure (Greenwich, Conn.)

Volumn 10, Issue 5, 2004, Pages 259-264

  Sica, Domenic A ^a   Hess, Michael ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ALDOSTERONE RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; POTASSIUM;

BLOOD; CONGESTIVE HEART FAILURE; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; HYPERKALEMIA; KIDNEY; PATHOPHYSIOLOGY; REVIEW; RISK FACTOR;

ADRENERGIC BETA-ANTAGONISTS; ALDOSTERONE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; HEART FAILURE, CONGESTIVE; HUMANS; HYPERKALEMIA; KIDNEY; POTASSIUM; RECEPTORS, ALDOSTERONE; RISK FACTORS;

MLCS; MLOWN;

EID: 16644365016     PISSN: 15275299     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1527-5299.2004.02814.x     Document Type: Review

References (45)